This article summarizes the role of AFP in the TME of HCC, especially discussing its effect on liver cancer stem cells, tumor-associated macrophages, cancer-associated fibroblasts (CAFs), endothelial cells, mesenchymal stem cells, tumor immune escape, etc., providing a reference for the clinical diagnosis and treatment of HCC. This evidence concerns the gene AFP and neoplasm.